Amanda McQuade and Nathaniel Robichaud discuss how integrated proteomic and transcriptomic profiling can reveal cellular responses to genetic perturbations that are not captured through RNA analysis ...
Multicenter prospective validation of PanClaudinAI: An AI for predicting Claudin 18.2 from CT in pancreatic cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers ...
Credit: Science Source “We call it living neuroscience,” says Crownlands cofounder and CEO Nate Dalva, who hopes the ...
Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, ...
Genomic and transcriptomic correlates of deep PSA response in patients with mHSPC. Despite major advances in combination treatment strategies for metastatic hormone-sensitive prostate cancer (mHSPC), ...
Presentations highlight the clinical utility of AI-powered models and multimodal profiling for biomarker discovery, treatment response prediction, and patient stratification across diverse solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results